Biotechnology Stocks II Performance Guide: C4 Therapeutics, Inc. (CCCC)
CCCC has no dividends.
Table and Chart of CCCC Performance
See what a $1,000 investment in CCCC is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| CCCC Returns | |
|---|---|
| Start Date | Nov-30-2020 |
| Start Price | $34.20 |
| End Date | Jul-26-2024 |
| End Price | $6.50 |
| # Prices | 45 |
| Min Date | Oct-31-2023 |
| Min Price | $1.49 |
| Max Date | Sep-30-2021 |
| Max Price | $44.68 |
| Total Return | -80.99% |
| Annualized Return | -35.78% |
| Current Value of $1,000 Purchase | $190 |
| Number Returns | 990 |
| Average Return | -37.12% |
| Number Profitable Returns | 195 |
| Percent Profitable Returns | 19.70% |
| Number Unprofitable Returns | 795 |
| Percent Unprofitable Returns | 80.30% |
| Profitable to Unprofitable Returns Ratio | 0.25 |
| CCCC Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $447,238,000 |
| Beta | 3.078 | Price to Sales | 24.49 |
| Earnings per Share | $-2.3700 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 2.065 |
| PRICE DATA | |
| 52 Week High | $11.88 |
| 52 Week Low | $1.06 |
| Analyst Target Price | $18.86 |
| 50-Day Moving Average | $5.23 |
| 200-Day Moving Average | $5.43 |
| FINANCIAL DATA | |
| Revenue per Share | $0.368 |
| Revenue | $20,036,000 |
| Profit Margin | 0% |
| Return on Equity | -48.4% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
CCCC Compare Returns with S&P 500
CCCC Trendline Chart
CCCC Moving Average Chart
CCCC Stock Return Map - See Patterns of Gains and Losses
CCCC Stock Returns/Purchase Dates